The CXCL12/CXCR4 produced by Prx1+ mesenchymal cells can be a target to eradicate parenchymal leukemia stem cells (LSCs) in acute myeloid leukemia (AML) [69]. The gene discussed is CXCR4; the disease is acute myeloid leukemia.